GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

The Orlando Magic ended a four-game losing streak in a big way Wednesday, scoring 130 points in a runaway victory at Sacramento.

American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between ...

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

The yen gained against the greenback and gold rose to a record high on haven demand. The 10-year Treasury yield dipped and an index of dollar strength extended losses, after US job openings fell in ...

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Fintech major BharatPe’s chief marketing officer Parth Joshi is stepping down from his position to ‘pursue an entrepreneurial ...

The medication will be sold under the brand name Journavx for $15.50 per pill, according to Vertex Pharmaceuticals, the company that developed the new drug. The FDA's sign-off on the medication comes ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...